… treatment of various diseases and tissue defects, including neurodegenerative diseases such
as spinal cord injury (SCI) and amyotrophic lateral sclerosis (… use in regenerative medicine. …

… Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug,
nutritional, and respiratory therapies (an evidence-based review): report of the Quality …

… Amyotrophic lateral sclerosis (… drug for the management of this disease, there is still no
definitive cure for it. In this regard, the use of mesenchymal stem cells (MSCs) for the treatment or …

… The clinical manifestations of sporadic amyotrophic lateral sclerosis (sALS) and familial
amyotrophic lateral sclerosis (fALS) are almost very similar, and the median age of onset of sALS …

… therapeutic approach in amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis is
a … effect against oxidative stress in amyotrophic lateral sclerosis. A study reported functions …

… Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset disease characterized by the …
Currently, no effective disease-modifying therapy is available for ALS, and riluzole, the only drug …

… CNS, is one of the main hallmarks of amyotrophic lateral sclerosis (ALS). Recently, a crucial
role of … is currently approved by both the FDA and the EMA for the treatment of psoriasis and …

… acute intermittent hypoxia is a recently reported non-pharmacological therapy that aims to …
of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an …

… Associations between type 2 diabetes (T2D) and amyotrophic lateral sclerosis (ALS) were
discovered in observational studies in both European and East Asian populations. However, …

… of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral
sclerosis … "clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. …